Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
Recruiting · NCT06407232 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Recruiting | Phase 3 | 2026-06-11 | NCT06407232 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| University of Wisconsin, Madison | 265 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UW Hospital and Clinics | Madison | United States | 9 |